22P-75798-59695 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-11
Dose 1 — Janssen/Johnson & Johnson
2021-03-12
Registered in v-safe
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · None

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-25
Health check-in — 14 day, dose 1
Feeling: Good

Adult check-in
2021-09-09
Survey response — 6 month, dose 1
MedDRA: Anosmia, Chest discomfort, Headache, Pyrexia, Rhinorrhoea, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11 · check-in answers available
2021-09-09
Report sent to call center — 6 month, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-09-13
Call 1 — Left Voicemail
2022-03-11
Survey response — 12 month, dose 1
MedDRA: Anosmia, Chills, Conjunctivitis, Cough, Headache, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-11	Janssen/Johnson & Johnson

Call center

Reported	Outcome	VAERS-related outcome
2021-09-09	Unsuccessful

Free text

Release 9

Symptoms: Headache, low grade fever, running nose, slight chest pressure, loss of smell

Healthcare visit (other): Ultrasound

Release 11

Symptoms: Loss of smell, conjunctivitis, fever, cough, runny nose, headache, chills

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Anosmia	·	·	✓
SD	Chest discomfort	·	·	✓
SD	Chills	·	·	✓
SD	Conjunctivitis	·	·	✓
SD	Cough	·	·	✓
SD	Headache	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release